7.705
Schlusskurs vom Vortag:
$7.48
Offen:
$7.41
24-Stunden-Volumen:
1.00M
Relative Volume:
1.63
Marktkapitalisierung:
$359.91M
Einnahmen:
$121.14M
Nettoeinkommen (Verlust:
$-32.33M
KGV:
-8.9593
EPS:
-0.86
Netto-Cashflow:
$-22.69M
1W Leistung:
+4.40%
1M Leistung:
+47.89%
6M Leistung:
+38.08%
1J Leistung:
-39.66%
Quanterix Corp Stock (QTRX) Company Profile
Firmenname
Quanterix Corp
Sektor
Branche
Telefon
617-301-9400
Adresse
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Vergleichen Sie QTRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
QTRX
Quanterix Corp
|
7.705 | 349.40M | 121.14M | -32.33M | -22.69M | -0.86 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-09-25 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-15 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-08-09 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | Hochstufung | Goldman | Sell → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Sell |
Alle ansehen
Quanterix Corp Aktie (QTRX) Neueste Nachrichten
How Quanterix Corporation stock reacts to job market dataJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - Newser
Nothing is Better Than Quanterix Corp (QTRX) stock at the moment - Setenews
Looking To Buy Quanterix Corp (QTRX)? Read This First - fostersleader.com
Is Quanterix Corporation stock supported by innovation pipelineMarket Activity Summary & Technical Entry and Exit Alerts - Newser
Ready to Jump After Recent Trade: Quanterix Corp (QTRX) - Setenews
CFO Sriram Acquires 548 Of Quanterix Corp [QTRX] - TradingView
CEO Toloue Acquires 1,238 Of Quanterix Corp [QTRX] - TradingView
Quanterix Corporation (QTRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Quanterix Corp Announces Board Changes - TradingView
Quanterix appoints new board members, names executive chair in leadership shift - Investing.com
Technical analysis overview for Quanterix Corporation stock2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
Long term hold vs stop loss in Quanterix CorporationTrade Exit Report & Low Drawdown Trading Strategies - newser.com
It is Poised to be a Bull Market for Quanterix Corp (QTRX) - Setenews
Is Quanterix Corporation stock undervalued vs historical averagesGlobal Markets & High Accuracy Buy Signal Tips - newser.com
Quanterix Nears All-Stock Deal for Akoya Biosciences - MSN
Is Quanterix Corporation stock a buy in volatile marketsMarket Movers & Daily Volume Surge Trade Alerts - newser.com
Quanterix (NASDAQ: QTRX) Study Backs Dual GFAP/NfL Blood Test for MS Monitoring - Stock Titan
Can a trend reversal in Quanterix Corporation lead to recoveryWeekly Investment Recap & Weekly Return Optimization Plans - newser.com
Quanterix FY2025 EPS Estimate Reduced by Leerink Partnrs - Defense World
What to expect from Quanterix Corporation in the next 30 daysGap Down & Weekly Market Pulse Alerts - newser.com
Why analysts upgrade Quanterix Corporation stockJuly 2025 Patterns & Long-Term Capital Growth Ideas - Fundação Cultural do Pará
Prepare Yourself for Liftoff: Quanterix Corp (QTRX) - Setenews
Q3 2025 Quanterix Corp Earnings Call Transcript - GuruFocus
Quanterix outlines $85M synergy target and signals 2026 cash flow breakeven as integration advances - MSN
Quanterix’s Sales Rise As Alzheimer’s Diagnostics Take Center Stage - Finimize
Quanterix Corporation (NASDAQ:QTRX) Q3 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Quanterix Q3 2025 sees revenue rise, EPS miss - Investing.com Nigeria
Quanterix Corp (QTRX) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Quanterix Corp (QTRX) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Quanterix (QTRX) Exceeds Revenue Estimates in Q3 - GuruFocus
[10-Q] Quanterix Corp Quarterly Earnings Report | QTRX SEC FilingForm 10-Q - Stock Titan
Quanterix earnings missed by $0.27, revenue topped estimates - Investing.com
[8-K] Quanterix Corp Reports Material Event | QTRX SEC FilingForm 8-K - Stock Titan
Quanterix (NASDAQ: QTRX) reports Q3 revenue $40.2M; $67M synergies captured - Stock Titan
Can Quanterix Corporation stock resist market sell offsJuly 2025 Drop Watch & Verified Technical Trade Signals - newser.com
What technical charts say about Quanterix Corporation stockJuly 2025 Chart Watch & Verified Momentum Watchlists - newser.com
Quanterix Corp expected to post a loss of 53 cents a shareEarnings Preview - TradingView
Earnings To Watch: Quanterix Corp (QTRX) Reports Q3 2025 Result - GuruFocus
Is Quanterix Corporation stock a defensive play in 2025Portfolio Performance Report & Long-Term Investment Growth Plans - newser.com
Why Quanterix Corporation stock could outperform in 2025July 2025 News Drivers & Safe Swing Trade Setup Alerts - newser.com
Quanterix Corporation’s volatility index tracking explainedTrade Risk Assessment & Weekly High Momentum Picks - newser.com
Finanzdaten der Quanterix Corp-Aktie (QTRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):